Company / Return on Assets (ROA)
Cardiff Oncology, Inc. Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-74.1%
FY2025
5-year range
-74.1% / -12.9%
FY2021-FY2025
Trend
-73.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) has fluctuated over the past 10 years, ranging from -319.1% in FY2017 to -12.9% in FY2021.
Based on SEC 10-K filings.
-74.1% in FY2025 with a 5-year CAGR of -59.8%.
Declined from -47.4% to -74.1% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -49.7pp
- 5-Year Change
- -59.8pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 73.8% year-over-year.
- Peak return on assets (roa) was recorded in FY2021.
- Lowest return on assets (roa) in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -74.1% | -73.8% |
| FY2024 | -42.6% | +10.1% |
| FY2023 | -47.4% | -94.7% |
| FY2022 | -24.3% | -88.6% |
| FY2021 | -12.9% | +9.9% |
| FY2020 | -14.3% | +88.6% |
| FY2019 | -125.4% | +28.6% |
| FY2018 | -175.7% | +44.9% |
| FY2017 | -319.1% | -879.2% |
| FY2016 | -32.6% | +15.2% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026